Delivery Order SPE2DR25D1202-SPE2DR26F74MK
Award Date 2/4/26
Potential Completion Date 2/26/26
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Zoladex 10.8 mg implant syringes, valued at $2,018.60. This firm fixed-price delivery order, which carries an ultimate completion date of February 20, 2026, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $17,636.58 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This competitively awarded, firm fixed-price contract was executed on December 3, 2025, with an ultimate completion date of December 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $20,186 delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 6, 2026. This firm fixed-price, non-set-aside contract represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $2,155.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zoladex 3.6 mg implant syringes, with an ultimate completion date of February 4, 2026. This competitively awarded contract carries no set-aside designation and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December...
- The Defense Logistics Agency awarded a $6,055.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 3, 2026. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The company...
- The Defense Logistics Agency (DLA) awarded a $2,155.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zoladex 3.6 mg implant syringes, with performance expected to conclude by February 19, 2026. The award was made on a non-set-aside, competitive basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order against AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,018.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 10, 2026. This non-set-aside delivery order was awarded on January 20, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,939.43 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. The contract, awarded on December 17, 2025, with a completion date of January 9, 2026, utilizes firm fixed-price pricing and carries no set-aside designation. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $5,878.86 for the supply of Zoladex 10.8 mg implant syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 29, 2025, and represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier to the federal government's military and healthcare systems. The work will be...
- The Defense Logistics Agency awarded a $5,578.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zoladex 10.8 mg implant syringes, with completion scheduled for October 14, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...